Trials / Completed
CompletedNCT01023386
A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer
A Clinical Pharmacological Study to Assess the Distribution, Metabolism, and Elimination of YM155 After i.v. Infusion in Patients With Advanced Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the pharmacokinetics of YM155, identifies the metabolic profile of YM155 and evaluates the safety and tolerability of YM155 after a 3-hour infusion in patients with advanced cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM155 | I.V. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2009-12-02
- Last updated
- 2010-04-13
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT01023386. Inclusion in this directory is not an endorsement.